Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials

• Үндсэн зохиолчид: Suiyuan Hu (Зохиогч), Chu Lin (Зохиогч), Xiaoling Cai (Зохиогч), Xingyun Zhu (Зохиогч), Fang Lv (Зохиогч), Wenjia Yang (Зохиогч), Linong Ji (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: The pleiotropic efficacy of SGLT2is in patients with different eGFR levels has not been well-understood. This systematic review and meta-analysis assessed the disparities in the efficacy and safety of SGLT2i treatment across stratified renal function.Methods: We searched four databases f...